MacroGenics
MGNX
#8706
Rank
ยฃ0.17 B
Marketcap
ยฃ2.74
Share price
-2.38%
Change (1 day)
130.22%
Change (1 year)

Earnings for MacroGenics (MGNX)

Earnings in 2026 (TTM): -ยฃ52.67 Million

According to MacroGenics's latest financial reports the company's current earnings are ยฃ0.15 Billion. In 2025 the company made an earning of -ยฃ55.85 Million a decrease over its 2024 earnings that were of -ยฃ48.98 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for MacroGenics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ52.67 Million-5.69%
2025 -ยฃ55.85 Million14.04%
2024 -ยฃ48.98 Million628.88%
2023 -ยฃ6.72 Million-92.44%
2022 -ยฃ88.83 Million-40.75%
2021 -ยฃ0.15 Billion55.79%
2020 -ยฃ96.24 Million-14.54%
2019 -ยฃ0.12 Billion-11.46%
2018 -ยฃ0.13 Billion773.65%
2017 -ยฃ14.56 Million-66.47%
2016 -ยฃ43.42 Million190.61%
2015 -ยฃ14.94 Million-47.43%
2014 -ยฃ28.42 Million14585.78%
2013 -ยฃ0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.85 B-15,010.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.08 B-43,919.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.74 B-12,893.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.95 B-15,203.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.75 B-18,616.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.11 B-13,611.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-ยฃ0.13 Billion 139.34%๐Ÿ‡บ๐Ÿ‡ธ USA